https://investor.ironwoodpharma.com/press-releases/press-release-details/2009/Ironwood-Announces-Linaclotide-European-Licensing-Agreement-With-Almirall/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- May 4, 2009